Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Other Accumulated Expenses (2017 - 2026)

Updated

Takeda Pharmaceutical's Other Accumulated Expenses came in at $3.59 billion for the quarter ended Jun 30, 2026, up 0.5% from $3.57 billion a year earlier but down 4.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical's Other Accumulated Expenses was $3.92 billion, up 0.2% from the prior year.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of -5.2% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Other Accumulated Expenses was $3.91 billion in the year ended Mar 31, 2025 (-8.8%), $4.29 billion in the year ended Mar 31, 2024 (+2.4%), $4.19 billion in the year ended Mar 31, 2023 (-19.5%) and $5.21 billion in the year ended Mar 31, 2022 (+1.8%).
  • The five-year range for quarterly Other Accumulated Expenses is $3.35 billion (the quarter ended Sep 30, 2024) to $5.03 billion (the quarter ended Mar 31, 2022).
  • Year-over-year, Other Accumulated Expenses increased in two of the last eight quarters, with an average decline of 3.9%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in the quarter ended Sep 30, 2025 (growth of 2.5%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 16.1%).
  • Business Quant data shows TAK's Other Accumulated Expenses at $3.76 billion (quarter ended Mar 31, 2026), $3.69 billion (quarter ended Dec 31, 2025) and $3.43 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.59 Bn
Mar 31, 2026 3.76 Bn
Dec 31, 2025 3.69 Bn
Sep 30, 2025 3.43 Bn
Jun 30, 2025 3.57 Bn
Mar 31, 2025 3.91 Bn
Dec 31, 2024 3.72 Bn
Sep 30, 2024 3.35 Bn
Jun 30, 2024 3.63 Bn
Mar 31, 2024 4.18 Bn
Dec 31, 2023 3.96 Bn
Sep 30, 2023 3.99 Bn
Jun 30, 2023 4.08 Bn
Mar 31, 2023 4.28 Bn
Dec 31, 2022 4.53 Bn
Sep 30, 2022 4.68 Bn
Jun 30, 2022 4.69 Bn
Mar 31, 2022 5.03 Bn
Jun 30, 2021 4.73 Bn
Mar 31, 2021 5.13 Bn
API Access

Takeda Pharmaceutical Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TAK&period=max&api_key=YOUR_API_KEY